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Clinics and pathology 
Disease 
Non Hodgkin lymphoma 
Clinics 
The t(3;12)(q27;p12) was found in a case of follicular 
lymphoma transformed to diffuse aggressive 
lymphoma, from a study with no individual data 
(Akasaka et al., 2003). 





706 amino acids; composed of a NH2-term BTB/POZ 
domain (amino acids 1-130 (32-99 according to Swiss-
Prot) which mediates homodimerization and protein-
protein interactions with other corepressors (including 
HDAC1 and NCOR2/SMRT to constitute a large 
repressing complex, another transcription repression 
domain (191-386), PEST sequences (300-417) with a 
KKYK motif (375-379), and six zinc finger at the C-
term (518-541, 546-568, 574-596, 602-624, 630-652, 
658-681), responsible for sequence specific DNA 
binding. Transcription repressor; recognizes the 
consensus sequence: TTCCT(A/C)GAA (Albagli-
Curiel, 2003). Role in germinal centers of lymphoid 
follicles. BCL6 prevents ATM and TP53 to induce 
apoptosis in response to DNA rearrangements such as 
somatic hypermutation and class switch recombination. 







LRMP is an integral membrane protein of the 
endoplasmic reticulum (ER), oriented on the ER 
membrane facing the cytosol.  
It is a lymphoid-restricted gene that is expressed in a 
developmentally regulated fashion (Behrens et al., 
1994).  
It may be involved in diabetes susceptibility (Grimm et 
al., 2003). A V141L polymorphism of LRMP has been 
found associated with a higher mortality in patients 
with lung cancer (Manenti et al., 2006).  
LRMP has recently been found involved in a 
translocation t(8;12)(q24;p12) with a LRMP/MYC 
fusion gene in non Hodgkin lymphoma (Singh et al., 
2012). 




Breakpoint in BCL6 first intron. 
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